The cosmetic surgery market would grow at a CAGR of 12.42% over the predicted time frame. The market is expected to increase in value from US$ 80.38 Bn in 2022 to US$ 205.1Bn in 2030.

Download Free Sample@ https://www.precedenceresearch.com/sample/2083

Report Scope of the Cosmetic Surgery Market

A recent report provides crucial insights along with application based and Forecast information in the Global Cosmetic surgery Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Cosmetic surgery market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Cosmetic surgery market are included as given below:

Cosmetic surgery Market Key Players

• Evolus Inc.
• RevanceGalderma
• AbbVie
• Cynosure
• Lumenis
• Solta Medical
• Alma Laser
• Syneron Candela

Market Segments

By Procedure

• Surgical Procedures
  • Breast Augmentation
  • Liposuction
  • Eyelid Surgery
  • Abdominoplasty
  • Rhinoplasty
  • Others
• Non-surgical Procedures
  • Botulinum Toxin
  • Hyaluronic Acid
  • Hair Removal
  • Nonsurgical Fat Reduction
  • Photo Rejuvenation
  • Others

By Gender

• Male
• Female

By Age 

• 13 - 29
• 30 - 54
• 55 plus

By End User

• Ambulatory Surgical Facility
• Hospital and Clinic
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa (MEA)

Report Objectives

• To define, describe, and forecast the global cosmetic surgery market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the cosmetic surgery market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Cosmetic Surgery Market 

5.1. COVID-19 Landscape: Cosmetic Surgery Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Cosmetic Surgery Market, By Procedure

8.1. Cosmetic Surgery Market, by Procedure, 2022-2030

8.1.1. Surgical Procedures

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Non-surgical Procedures

8.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Cosmetic Surgery Market, By Gender

9.1. Cosmetic Surgery Market, by Gender, 2022-2030

9.1.1. Male

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Female

9.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Cosmetic Surgery Market, By Age 

10.1. Cosmetic Surgery Market, by Age, 2022-2030

10.1.1. 13 - 29

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. 30 - 54

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. 55 plus

10.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Cosmetic Surgery Market, By End User 

11.1. Cosmetic Surgery Market, by End User, 2022-2030

11.1.1. Ambulatory Surgical Facility

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Hospital and Clinic

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Others

11.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Cosmetic Surgery Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.1.2. Market Revenue and Forecast, by Gender (2017-2030)

12.1.3. Market Revenue and Forecast, by Age (2017-2030)

12.1.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Gender (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Age (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Gender (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Age (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End User (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Gender (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Age (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End User (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Gender (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Age (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End User (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Procedure (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Gender (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Age (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End User (2017-2030)

Chapter 13. Company Profiles

13.1. Evolus Inc.

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. RevanceGalderma

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. AbbVie

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Cynosure

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Lumenis

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Solta Medical

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Alma Laser

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Syneron Candela

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: [email protected]

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com